Completed Trial: Corsano CardioWatch 287-2 vs Standard Cuff for Tracking Blood Pressure Treatment Response — Remote Monitoring Validation

References

1. 1.Australian Bureau of Statistics. (2023). National Health Survey: First Results, 2022 (4364.0.55.001). ABS. https://www.abs.gov.au/statistics/health/health-conditions-and-risks/national-health-survey-first-results/2022
2. 2.Corsano Health B.V. (2024). Blood Pressure Treatment by the Corsano CardioWatch 287-2 Evaluation Study. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT06508619
3. 3.Parati, G., Stergiou, G. S., & Dolan, E. (2018). Blood pressure variability: clinical relevance and application. Journal of Clinical Hypertension, 20(7), 1133-1137. https://doi.org/10.1111/jch.13304
4. 4.Pickering, T. G., James, G. D., Boddie, C., Harshfield, G. A., Blank, S., & Laragh, J. H. (1988). How common is white coat hypertension? JAMA, 259(2), 225-228. https://doi.org/10.1001/jama.1988.03720090014020
5. 5.Tucker, K. L., Sheppard, J. P., Stevens, R., Bosworth, H. B., Bove, A., Bray, E. P., ... & McManus, R. J. (2017). Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Medicine, 14(9), e1002389. https://doi.org/10.1371/journal.pmed.1002389
6. 6.Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., ... & Wright, J. T. (2018). 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension, 71(6), e13-e115. https://doi.org/10.1161/HYP.0000000000000065